Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: Biopersistence of nanoparticles and possible solutions

Journal of Applied Toxicology

Volumn 33, Issue 10, 2013, Pages 1089-1096

  Seok, Seung Hyeok ^a   Cho, Wan Seob ^b   Park, Jung Shin ^a   Na, Yirang ^a   Jang, Ahram ^a   Kim, Hojoong ^c   Cho, Yujin ^c   Kim, Taesung ^c   You, Ji Ran ^d   Ko, Sanghoon ^e   Kang, Byeong Cheol ^d   Lee, Jong Kwon ^f   Jeong, Jayoung ^f   Che, Jeong Hwan ^d  

^a Seoul National University College of Medicine   (South Korea)

^b Dong A University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e Sejong University   (South Korea)

^f Korea Food and Drug Administration   (South Korea)

Author keywords

Anemia; Bio persistence; Nanoparticles; OECD test guideline; Oral toxicity; Pancreatitis

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHELATING AGENT; CHLORIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; NANOPARTICLE; PHOSPHORUS; POTASSIUM; PROTEIN; SODIUM; TRIACYLGLYCEROL; ZINC OXIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOLOGICAL FUNCTIONS; BIOPERSISTENCE; CALCIUM BLOOD LEVEL; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HISTOLOGY; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; STOMACH ADENOCARCINOMA; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN;

RATTUS;

EID: 84880953917     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2862     Document Type: Article

References (24)

1. Blanusa M, Varnai VM, Piasek M, Kostial K. 2005. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr. Med. Chem. 12: 2771-2794.
2. Cho WS, Cho M, Jeong J, Choi M, Han BS, Shin HS, Hong J, Chung BH, Cho MH. 2010. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 245: 116-123.
3. Cho WS, Duffin R, Howie SE, Scotton CJ, Wallace WA, Macnee W, Bradley M, Megson IL, Donaldson K. 2011. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part. Fibre Toxicol. 8: 27.
4. Chun AL. 2009. Will the public swallow nanofood? Nat. Nanotechnol. 4: 790-791.
5. ENV/JM/MONO 46. 2010. Series on the safety of manufactured nanomaterials No.27. List of Manufactured Nanomaterials and List of Endpoints for Phase One of the Sponsorship Programme for the Testing of Manufactured Nanomaterials: revision OECD.
6. Fallingborg J. 1999. Intraluminal pH of the human gastrointestinal tract. Dan. Med. Bull. 46: 183-196.
7. Ferahman M, Unal E, Sakoglu N, Ersoy YE, As A, Ozdemir S. 2003. Zinc and copper status in acute pancreatitis: an experimental study. Biol. Trace Elem. Res. 91: 89-94.
8. Hilty FM, Arnold M, Hilbe M, Teleki A, Knijnenburg JT, Ehrensperger F, Hurrell RF, Pratsinis SE, Langhans W, Zimmermann MB. 2010. Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation. Nat. Nanotechnol. 5: 374-380.
9. Hoffman HN 2nd, Phyliky RL, Fleming CR. 1988. Zinc-induced copper deficiency. Gastroenterology 94: 508-512.
10. Latimer KS, Jain AV, Inglesby HB, Clarkson WD, Johnson GB. 1989. Zinc-induced hemolytic anemia caused by ingestion of pennies by a pup. J. Am. Vet. Med. Assoc. 195: 77-80.
11. Maret W, Jacob C, Vallee BL, Fischer EH. 1999. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Natl. Acad. Sci. U.S.A. 96: 1936-1940.
12. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. 2006. Safe handling of nanotechnology. Nature 444: 267-269.
13. Maynard AD, Warheit DB, Philbert MA. 2011. The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol. Sci. 120(Suppl 1): S109-129.
14. Mikszewski JS, Saunders HM, Hess RS. 2003. Zinc-associated acute pancreatitis in a dog. J. Small Anim. Pract. 44: 177-180.
15. Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y, Zhu G. 2011. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J. Am. Chem. Soc. 133: 8778-8781.
16. Muller KH, Kulkarni J, Motskin M, Goode A, Winship P, Skepper JN, Ryan MP, Porter AE. 2010. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano 4: 6767-6779.
17. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. 2012. Toxicity of zinc oxide nanoparticles through oral route. Toxicol. Ind. Health 28: 675-686.
18. Rashidi L, Khosravi-Darani K. 2011. The applications of nanotechnology in food industry. Crit. Rev. Food Sci. Nutr. 51: 723-730.
19. Rudolf E, Cervinka M. 2010. Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes. Biometals 23: 339-354.
20. Torrance AG, Fulton RB Jr. 1987. Zinc-induced hemolytic anemia in a dog. J. Am. Vet. Med. Assoc. 191: 443-444.
21. Wang B, Feng W, Wang M, Wang T, Gu Y, Zhu M, Ouyang H, Shi J, Zhang F, Zhao Y, Chai Z, Wang H, Wang J. 2008. Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice. J. Nanoparticle. Res. 10: 263-276.
22. Wiesenthal A, Hunter L, Wang S, Wickliffe J, Wilkerson M. 2011. Nanoparticles: small and mighty. Int. J. Dermatol. 50: 247-254.
23. Wurster DE, Burke GM, Berg MJ, Veng-Pedersen P, Schottelius DD. 1988. Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals. Pharm. Res. 5: 183-186.
24. Yanagisawa H, Miyakoshi Y, Kobayashi K, Sakae K, Kawasaki I, Suzuki Y, Tamura J. 2009. Long-term intake of a high zinc diet causes iron deficiency anemia accompanied by reticulocytosis and extra-medullary erythropoiesis. Toxicol. Lett. 191: 15-19.